FFT Wealth Management LLC Sells 1,025 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

FFT Wealth Management LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.7% in the fourth quarter, HoldingsChannel reports. The firm owned 17,091 shares of the exchange traded fund’s stock after selling 1,025 shares during the quarter. FFT Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,539,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF in the third quarter worth about $141,284,000. Assetmark Inc. boosted its stake in SPDR S&P Biotech ETF by 72,653.0% in the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after acquiring an additional 588,489 shares during the last quarter. Mirae Asset Securities USA Inc. boosted its stake in SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares during the last quarter. Finally, Sivik Global Healthcare LLC bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at approximately $29,640,000.

SPDR S&P Biotech ETF Trading Down 1.6 %

NYSEARCA:XBI opened at $88.69 on Wednesday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The firm’s 50 day moving average is $91.14 and its 200 day moving average is $95.92. The stock has a market capitalization of $6.76 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.